Healthcare & Life Scienceshttps://www.bakermckenzie.com/en/rss-landing/industries/healthcareHealthcare & Life Sciencesen{30947232-2B34-4E7C-80D6-BAB3F5EBAE7E}https://www.bakermckenzie.com/en/insight/publications/2026/06/european-union-european-health-data-space-and-trade-secretsData, Technology, Privacy & CybersecurityHealthcare & Life SciencesIntellectual PropertyEuropean Union: European Health Data Space and Trade SecretsTue, 16 Jun 2026 00:00:00 Z{26F6E100-C00C-4999-9657-8EE48E4743BA}https://www.bakermckenzie.com/en/insight/publications/2026/06/convergence-of-risk-cyber-data-ai-disputesArtificial IntelligenceDispute ResolutionData, Technology, Privacy & CybersecurityIndustrials, Manufacturing & TransportationConsumer Goods & RetailHealthcare & Life SciencesTechnologyFinancial InstitutionsEnergy & InfrastructureThe Convergence of Risk: Cyber, Data and AI DisputesMon, 15 Jun 2026 00:00:00 Z{961A8786-6EAF-459F-9C92-D10EFE44135A}https://www.bakermckenzie.com/en/insight/publications/guides/ukrainian-laws-in-wartimeKyivHealthcare & Life SciencesBanking & FinanceEmployment & CompensationTaxReal EstateIntellectual PropertyAntitrust & CompetitionFinancial InstitutionsUkrainian Laws in WartimeWed, 10 Jun 2026 00:00:00 Z{8BAA1E86-4383-4BF3-8A84-866DBC6810BD}https://www.bakermckenzie.com/en/newsroom/2026/06/bain-capital-life-sciences-swixx-biopharmaInternational Commercial & TradePrivate EquityTaxHealthcare & Life SciencesBaker McKenzie Advises Bain Capital Life Sciences on Investment in Swixx BioPharmaFri, 05 Jun 2026 00:00:00 Z{57066E27-8BCF-4871-861A-072F23DD9B1B}https://www.bakermckenzie.com/en/newsroom/2026/06/forbes-inaugural-list-of-americas-top-women-lawyersMergers & AcquisitionsTechnologyHealthcare & Life SciencesTaxState & Local TaxMaria Eberle and Aarthi Belani Named to Forbes’ Inaugural List of America’s Top Women LawyersFri, 05 Jun 2026 00:00:00 Z{D15C07C4-E207-4DCF-8337-26AFF7A94E3A}https://www.bakermckenzie.com/en/insight/publications/2026/05/singapore-hsas-clampdown-on-illegal-health-productsSingaporeHealthcare & Life SciencesConsumer HealthcareSingapore: HSA’s Clampdown on Illegal Health ProductsFri, 29 May 2026 00:00:00 Z{C10BCD4F-2E2D-4577-81EE-CDEEEA98785E}https://www.bakermckenzie.com/en/insight/publications/2026/05/singapore-hsas-collaboration-with-overseas-regulatorsSingaporeHealthcare & Life SciencesSingapore: HSA’s Collaboration with Overseas RegulatorsFri, 29 May 2026 00:00:00 Z{93C21759-8FF9-4743-97EB-A4163FC78280}https://www.bakermckenzie.com/en/newsroom/2026/05/daniel-garcia-legal-gaps-orbital-research-springer-natureHealthcare & Life SciencesPharmaceuticals & BiotechLife Sciences TransactionsTechnologyIntellectual PropertyData, Technology, Privacy & CybersecurityBaker McKenzie Counsel Daniel Garcia Explores Legal Gaps in Orbital Research in Springer NatureFri, 22 May 2026 00:00:00 Z{D445791D-B21B-464D-8EDF-3E12E133B6FD}https://www.bakermckenzie.com/en/insight/publications/2026/05/australia-budget-bites-healthcareBrisbaneMelbourneSydneyTaxHealthcare & Life SciencesAustralia: Budget Bites — HealthcareTue, 12 May 2026 00:00:00 Z{BAD464E7-D8DD-4310-92ED-567D6D6DBFAF}https://www.bakermckenzie.com/en/insight/publications/2026/05/australia-budget-bites-digital-healthBrisbaneMelbourneSydneyTaxHealthcare & Life SciencesAustralia: Budget Bites — Digital HealthTue, 12 May 2026 00:00:00 Z{9CEF581B-DCAC-48DA-B98F-598A359096A5}https://www.bakermckenzie.com/en/newsroom/2026/05/katherine-hanniford-in-washington-dcTechnologyData, Technology, Privacy & CybersecurityHealthcare & Life SciencesInvestigations, Compliance & EthicsBaker McKenzie Welcomes Cybersecurity and Data Privacy Attorney Katherine Hanniford in Washington, DCMon, 11 May 2026 00:00:00 Z{52229013-5252-4A0E-B436-36FAABD44CE0}https://www.bakermckenzie.com/en/insight/publications/2026/05/middle-east-pharmaceutical-supply-chains-under-gulf-geopolitical-pressureBahrainAbu DhabiDubaiRiyadhHealthcare & Life SciencesMiddle East: Pharmaceutical Supply Chains Under Gulf Geopolitical PressureFri, 08 May 2026 00:00:00 Z{E15E54E8-F270-483B-A63F-4FA80F1BC274}https://www.bakermckenzie.com/en/newsroom/2026/05/bayer-acquisition-of-perfuse-therapeuticsTransactionsMergers & AcquisitionsHealthcare & Life SciencesLife Sciences TransactionsPharmaceuticals & BiotechBaker McKenzie Advises Bayer on USD 2.45 billion Acquisition of Perfuse TherapeuticsWed, 06 May 2026 00:00:00 Z{3EF99F8E-772B-41AA-97A2-49CB5DA3555E}https://www.bakermckenzie.com/en/newsroom/2026/05/stada-acquisition-rights-locobaseMergers & AcquisitionsHealthcare & Life SciencesBaker McKenzie has advised STADA on the acquisition of rights to Locobase® from Karo HealthcareTue, 05 May 2026 00:00:00 Z{F6D49B22-6A06-4EA3-8D87-C5017BE6200E}https://www.bakermckenzie.com/en/insight/publications/2026/04/singapore-hsa-publishes-therapeutic-product-registrationSingaporeHealthcare & Life SciencesSingapore: HSA Publishes Therapeutic Product Registration UpdatesTue, 28 Apr 2026 00:00:00 Z{0D59F395-54E9-4C32-9A12-C0D9A8FED2D2}https://www.bakermckenzie.com/en/insight/publications/2026/04/singapore-moh-publishes-cybersecurity-and-data-securitySingaporeHealthcare & Life SciencesSingapore: MOH Publishes Cybersecurity and Data Security EssentialsTue, 28 Apr 2026 00:00:00 Z{DF3AD6C5-5D74-4C28-9811-2C800EB52578}https://www.bakermckenzie.com/en/insight/publications/2026/04/singapore-moh-publishes-health-information-act-resourcesSingaporeHealthcare & Life SciencesSingapore: MOH Publishes Health Information Act ResourcesTue, 28 Apr 2026 00:00:00 Z{151CDB2F-27F1-4270-A035-925AD340CA14}https://www.bakermckenzie.com/en/newsroom/2026/04/merit-medical-acquires-view-point-medicalTransactionsMergers & AcquisitionsHealthcare & Life SciencesLife Sciences TransactionsMedical DevicesBaker McKenzie Advises Merit Medical on the Acquisition of View Point MedicalTue, 07 Apr 2026 00:00:00 Z{E70B46C7-959F-4516-B6F0-DB2017A2B5BA}https://www.bakermckenzie.com/en/newsroom/2026/04/baker-mckenzie-advises-consortium-led-by-spe-capitalMergers & AcquisitionsHealthcare & Life SciencesBaker McKenzie Advises a Consortium led by SPE Capital, and included EBRD, Proparco and BIO on their Investment in Leading Ophthalmic Pharmaceutical ManufacturerWed, 01 Apr 2026 00:00:00 Z{FEB43FDA-C249-4E90-9AA5-50F1AD528082}https://www.bakermckenzie.com/en/insight/publications/2026/03/singapore-hsa-attains-highest-who-certificationSingaporeHealthcare & Life SciencesSingapore: HSA Attains Highest WHO CertificationTue, 31 Mar 2026 00:00:00 Z{8A20767D-3FBC-432A-9CF1-1EC1BBBCEFD8}https://www.bakermckenzie.com/en/insight/publications/2026/03/singapore-moh-and-hsa-launch-refreshed-ai-in-healthcare-guidelinesSingaporeHealthcare & Life SciencesSingapore: MOH and HSA Launch Refreshed AI in Healthcare GuidelinesTue, 31 Mar 2026 00:00:00 Z{3BAE3CF2-649E-4A6B-B676-E4D66802662C}https://www.bakermckenzie.com/en/insight/publications/2026/03/singapore-revisions-to-the-sapi-code-from-march-2026SingaporeHealthcare & Life SciencesSingapore: Revisions to the SAPI Code from March 2026Tue, 31 Mar 2026 00:00:00 Z{A81A5820-E14D-4B16-8658-8AD5E54C0916}https://www.bakermckenzie.com/en/insight/publications/2026/03/united-states-trump-launches-nationwide-antifraud-task-forceInvestigations, Compliance & EthicsDispute ResolutionHealthcare & Life SciencesUnited States Administration Launches Nationwide Anti‑Fraud Task ForceThu, 26 Mar 2026 00:00:00 Z{0F28D790-7CAC-409A-858F-BFE1C6573B2B}https://www.bakermckenzie.com/en/newsroom/2026/03/sunway-healthcare-ipoSingaporeLondonCapital MarketsHealthcare & Life SciencesFinancial InstitutionsEquity & Debt TransactionsTransactionsBaker McKenzie Advises Joint Bookrunners on Sunway Healthcare’s MYR 3.28 Billion IPOWed, 18 Mar 2026 00:00:00 Z{357FD6D6-AC7E-4547-B145-D8FABD7A57B6}https://www.bakermckenzie.com/en/newsroom/2026/03/sino-biopharm-exclusive-license-agreementHong KongAntitrust & CompetitionMergers & AcquisitionsPrivate EquityHealthcare & Life SciencesIntellectual PropertyBaker McKenzie Advises Sino Biopharm on up to US$1.53 Billion Exclusive License Agreement with Sanofi for RovadicitinibThu, 12 Mar 2026 00:00:00 Z{18E19B63-E5E8-4526-8A2D-0AAEE633CAB7}https://www.bakermckenzie.com/en/newsroom/2026/03/medtronic-carve-out-and-spinoff-of-minimedMergers & AcquisitionsCarve-outsCorporate ReorganizationsHealthcare & Life SciencesEmployment & CompensationAntitrust & CompetitionIntellectual PropertyTaxBaker McKenzie Acts as Global Counsel to Medtronic plc on the Carve-out and Spin-off of their Diabetes business, MiniMed Group, Inc. Wed, 11 Mar 2026 00:00:00 Z{A925B80F-DBC7-4E49-BDFC-EA145A42D4FD}https://www.bakermckenzie.com/en/newsroom/2026/03/servier-acquisition-day-one-biopharmaceuticalsTransactionsMergers & AcquisitionsHealthcare & Life SciencesBaker McKenzie Advises Servier on the Acquisition of Day One Biopharmaceuticals for Approximately USD 2.5 BillionTue, 10 Mar 2026 00:00:00 Z{64B5E651-BAC3-40C3-B7F9-30D3E92AD813}https://www.bakermckenzie.com/en/insight/publications/2026/02/singapore-hsa-releases-ai-medical-softwareSingaporeHealthcare & Life SciencesSingapore: HSA Releases AI Medical Software Consultation FindingsFri, 27 Feb 2026 00:00:00 Z{33964808-3C8E-4F64-8BF3-2D1AF67942C6}https://www.bakermckenzie.com/en/insight/publications/2026/02/singapore-hsa-updates-defect-reportingSingaporeHealthcare & Life SciencesSingapore: HSA Updates Defect Reporting and Recall GuidanceFri, 27 Feb 2026 00:00:00 Z{B38953C7-9122-457D-BE96-ABC5BF00779D}https://www.bakermckenzie.com/en/insight/publications/2026/02/how-does-indias-union-budget-apply-to-your-strategic-growth-plansMergers & AcquisitionsInternational Commercial & TradeData, Technology, Privacy & CybersecurityTaxHealthcare & Life SciencesEnergy & InfrastructureIndustrials, Manufacturing & TransportationEnergy & InfrastructureHow Does India's Union Budget Apply to Your Strategic Growth Plans?Tue, 10 Feb 2026 00:00:00 Z{D4563EBD-6676-4FA1-8524-2C4C68776764}https://www.bakermckenzie.com/en/insight/publications/2026/02/south-africa-who-2025-global-tax-reportsJohannesburgTaxHealthcare & Life SciencesSouth Africa: WHO 2025 Global Tax ReportsMon, 09 Feb 2026 00:00:00 Z{B8C34CC3-84D6-403F-BFCC-D2B2D1408C2B}https://www.bakermckenzie.com/en/insight/publications/2026/02/vietnam-new-circular-enhances-customs-ip-enforcementHanoiHo Chi Minh CityIntellectual PropertyHealthcare & Life SciencesConsumer Goods & RetailVietnam: New Circular Enhances Customs IP EnforcementThu, 05 Feb 2026 00:00:00 Z{B8BB79AD-B988-4B8A-BA41-7AE5A8BE1529}https://www.bakermckenzie.com/en/insight/publications/2026/01/singapore-regulatory-updates-for-therapeutic-product-registrationSingaporeHealthcare & Life SciencesSingapore: Regulatory Updates for Therapeutic Product RegistrationThu, 29 Jan 2026 00:00:00 Z{DA122FAF-F97D-452D-AB6F-17567F7E681B}https://www.bakermckenzie.com/en/insight/publications/2026/01/singapore-health-information-bill-passed-in-parliamentSingaporeHealthcare & Life SciencesSingapore: Health Information Bill Passed in ParliamentThu, 29 Jan 2026 00:00:00 Z{0CD74C76-17A5-404F-8BB0-BA6AAEAF225F}https://www.bakermckenzie.com/en/insight/publications/2026/01/united-states-the-biosecure-act-becomes-lawHealthcare & Life SciencesInternational Commercial & TradeUnited States: The BIOSECURE Act Becomes LawMon, 19 Jan 2026 00:00:00 Z{99224EBE-FD43-4709-8A31-A8E28D2F3C5E}https://www.bakermckenzie.com/en/insight/publications/2026/01/international-manufacturing-site-divestituresMergers & AcquisitionsHealthcare & Life SciencesSupply ChainsInternational: Manufacturing Site DivestituresFri, 09 Jan 2026 00:00:00 Z{DAA70CFE-085B-4947-96CD-630D0375257E}https://www.bakermckenzie.com/en/newsroom/2026/01/acquisition-of-iq-messengerMergers & AcquisitionsBanking & FinanceData, Technology, Privacy & CybersecurityEmployment & CompensationHealthcare & Life SciencesIntellectual PropertyPrivate EquityReal EstateBaker McKenzie advises Main Capital Partners on the acquisition of IQ MessengerThu, 08 Jan 2026 00:00:00 Z{55E7E0AC-0323-4696-A5F3-AF389507A37E}https://www.bakermckenzie.com/en/insight/publications/alerts/2025/12/singapore-hsa-expands-digital-portal-for-gene-therapiesSingaporeHealthcare & Life SciencesSingapore: HSA expands digital portal for gene therapiesMon, 29 Dec 2025 00:00:00 Z{9EC46747-9F74-4D78-8676-0F098745DAAE}https://www.bakermckenzie.com/en/insight/publications/alerts/2025/12/singapore-hsa-expands-regulatory-innovation-partnerships-and-ai-focusSingaporeHealthcare & Life SciencesSingapore: HSA expands regulatory innovation partnerships and AI focusMon, 29 Dec 2025 00:00:00 Z{9E6EDE98-1202-4F37-837D-AB2890518DFC}https://www.bakermckenzie.com/en/newsroom/2025/12/chambers-asia-pacific-2026Banking & FinanceIntellectual PropertyData, Technology, Privacy & CybersecurityFunds & Investment ManagementPrivate EquityHealthcare & Life SciencesTechnologyIslamic FinanceMergers & AcquisitionsDispute ResolutionEmployment & CompensationEnergy & InfrastructureTaxReal EstateInternational Commercial & TradeAviation, Aerospace & DefenseCapital MarketsAntitrust & CompetitionInsuranceBaker McKenzie Earns 149 Practice and 226 Individual Rankings in Chambers Asia Pacific 2026Fri, 12 Dec 2025 00:00:00 Z{93FD672E-C347-4D89-B775-D0C1BA111626}https://www.bakermckenzie.com/en/insight/publications/alerts/2025/11/singapore-introduction-of-the-health-information-bill-in-parliamentSingaporeHealthcare & Life SciencesSingapore: Introduction of the Health Information Bill in parliamentFri, 28 Nov 2025 00:00:00 Z{06D168F1-0E63-4FEC-8DC0-41CC4FAD0F3E}https://www.bakermckenzie.com/en/insight/publications/alerts/2025/11/singapore-hsa-warns-of-adulterated-herbal-productSingaporeHealthcare & Life SciencesSingapore: HSA warns of adulterated herbal productFri, 28 Nov 2025 00:00:00 Z{3973206B-C676-4971-841B-2E7A9219BBFB}https://www.bakermckenzie.com/en/newsroom/2025/11/sale-of-citieffe-group-to-polymedZurichMergers & AcquisitionsTaxDispute ResolutionInternational Commercial & TradeHealthcare & Life SciencesMedical DevicesBaker McKenzie Advises Current Shareholders (Including Funds Advised by ARCHIMED as Controlling Shareholder) on the Sale of Citieffe Group to PolyMedTue, 25 Nov 2025 00:00:00 Z{EC38002C-BDF2-409C-9B82-0736D7EB433A}https://www.bakermckenzie.com/en/newsroom/2025/11/fierce-biotech-jefferies-conferenceBanking & FinanceCapital MarketsMergers & AcquisitionsHealthcare & Life SciencesJane Hobson and Roel Meers Provide Insights to Fierce Biotech During Jefferies Global Healthcare ConferenceTue, 25 Nov 2025 00:00:00 Z{D9B0D0B3-0E89-4BE0-AA0C-B134E5C41C40}https://www.bakermckenzie.com/en/insight/publications/alerts/2025/11/venezuela-new-automated-platform-now-required-for-health-and-sanitaryInternational Commercial & TradeHealthcare & Life SciencesVenezuela: New Automated Platform Now Required for Health and Sanitary Procedures Fri, 14 Nov 2025 00:00:00 Z{EE01511C-61E7-48EF-990A-0B62A4FEFDD7}https://www.bakermckenzie.com/en/insight/publications/alerts/2025/11/brazil-regulatory-sandbox-custom-personal-care-products-cosmetics-perfumesHealthcare & Life SciencesConsumer HealthcareBrazil: Regulatory sandbox – customized personal care products, cosmetics, and perfumesFri, 07 Nov 2025 00:00:00 Z{E61E31A5-8CA9-4E4D-855F-B86BC6A33D5A}https://www.bakermckenzie.com/en/insight/publications/alerts/2025/11/egypt-the-eca-strikes-again-in-the-pharmaceutical-sectorAntitrust & CompetitionHealthcare & Life SciencesCartels & Antitrust InvestigationsEgypt: The ECA Strikes Again in the Pharmaceutical SectorThu, 06 Nov 2025 00:00:00 Z{AC57345E-47D8-446D-B109-464B6D2350D4}https://www.bakermckenzie.com/en/insight/publications/2025/11/opportunities-for-innovators-investors-strategic-partnersData, Technology, Privacy & CybersecurityDispute ResolutionEmployment & CompensationInternational Commercial & TradeMergers & AcquisitionsHealthcare & Life SciencesMedical DevicesPharmaceuticals & BiotechTransactional IPSupply ChainsOpportunities for Innovators, Investors and Strategic PartnersThu, 06 Nov 2025 00:00:00 Z{29256C3B-E9B6-4DC7-86D0-4E0064DBD588}https://www.bakermckenzie.com/en/insight/publications/alerts/2025/11/thailand-telepharmacy-and-expanding-access-to-medicinesBangkokHealthcare & Life SciencesThailand: Telepharmacy and Expanding Access to MedicinesWed, 05 Nov 2025 00:00:00 Z{DFAE93B8-3FB1-4964-8F05-004C787979A1}https://www.bakermckenzie.com/en/newsroom/2025/10/keensight-capital-acquisition-majority-stake-bedfont-scientificLondonBanking & FinancePrivate EquityHealthcare & Life SciencesBaker McKenzie advises on Keensight Capital’s acquisition of a majority stake in Bedfont Scientific Ltd.Fri, 31 Oct 2025 00:00:00 Z